Screening for dementia - is it a no brainer?
Screening for dementia - is it a no brainer?
复制标题
DOI：
10.1111/ijcp.12239
复制
发表时间：
2013-11-01
影响因子：
2.6
通讯作者：
Brayne, C.
中科院分区：
文献类型：
--
作者：
Fox, C.;Lafortune, L.;Brayne, C.
As people are living longer, dementia is becoming a significant issue for society. Dementia is now recognised as a major concern in society, and the numbers of people estimated to have dementia in the UK population appear to have stabilised at around 700,000 . Globally, 35.6 million people are estimated to meet criteria for dementia, a number predicted to double every 20 years . Given the absence of treatments that significantly alter the natural history of the clinical syndrome of dementia, there has been increased emphasis on early diagnosis, with research exploring assessment tools and biomarkers that might predict with certainty a particular clinical outcome. At the same time, there has been pressure to focus on biomedical profiles, which assume a very close link between the pathobiology and the manifest clinical syndrome.
